Among the 73 genes were a number of established cancer driver genes and validated drug targets, including ERBB2, EGFR and PIK3CA. Since the majority of the genes were clustered in amplicons throughout the genome, we further calculated the “cancer driver score” for each gene by calculating the correlation between its copy number and mRNA expression in each TCGA cancer subtype. The gene discussed is ERBB2; the disease is cancer.